Posted by Michael Wonder on 04 Jan 2018
Several drug makers just raised their prices by nearly 10 percent, and buyers expect more price hikes
2 January 2018 - Several drug makers celebrated the new year with substantial single-digit price hikes, while a new survey indicated that prices for brand-name medicines are expected to rise 3-4% annually over the next three years.
Leading the way among drug makers was Allergan, which boosted the list prices for 18 medicines by 9.5%, a level that allowed the company to stick to its controversial pledge to avoid double-digit price hikes. That move was made as part of a so-called social contract issued more than a year ago amid mounting anger over the cost of medicines.
Only a few other drug makers formally agreed to follow suit.
